Does ASCIMINIB Cause Second primary malignancy? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Second primary malignancy have been filed in association with ASCIMINIB (SCEMBLIX). This represents 0.3% of all adverse event reports for ASCIMINIB.
7
Reports of Second primary malignancy with ASCIMINIB
0.3%
of all ASCIMINIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Second primary malignancy From ASCIMINIB?
Of the 7 reports, 1 (14.3%) resulted in death, 3 (42.9%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ASCIMINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ASCIMINIB Cause?
Fatigue (193)
Death (144)
Nausea (138)
Thrombocytopenia (125)
Drug ineffective (117)
Diarrhoea (103)
Drug intolerance (98)
Headache (91)
Rash (86)
Pleural effusion (75)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which ASCIMINIB Alternatives Have Lower Second primary malignancy Risk?
ASCIMINIB vs ASCORBIC ACID
ASCIMINIB vs ASCORBIC ACID\FERROUS
ASCIMINIB vs ASCORBIC ACID\FERROUS\FOLIC ACID
ASCIMINIB vs ASCORBIC ACID\POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM ASCORBATE\SODIUM\SODIUM
ASCIMINIB vs ASENAPINE